Potential molecular mechanisms underlying the effect of arsenic on angiogenesis

Juan Zhang1, Yue Zhang1, Weiyan Wang1

  • 1Department of Rheumatology, The First Affiliated Hospital, Harbin Medical University, Nan Gang, Harbin, China.

Insights

Arsenic has dual effects on angiogenesis, acting as both an anti-cancer agent by inhibiting neovascularization and a carcinogen that promotes it. Understanding these mechanisms is key for its therapeutic application.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Arsenic compounds are utilized in cancer chemotherapy, primarily by inhibiting angiogenesis.
  • Angiogenesis is crucial in the progression of various diseases, making arsenic a potential therapeutic agent for conditions like rheumatoid arthritis and psoriasis.
  • Conversely, arsenic is also recognized as a carcinogen with pro-angiogenic properties, highlighting a complex role in neovascularization.

Purpose of the Study:

  • To review the dual effects of arsenic on neovascularization.
  • To elucidate the underlying mechanisms responsible for arsenic's influence on angiogenesis.
  • To provide a rational basis for the clinical application of arsenic in treating angiogenic diseases.

Main Methods:

  • This review synthesizes existing literature on arsenic's effects on angiogenesis.
  • Mechanisms of action are analyzed from various biochemical and cellular studies.
  • Clinical data on arsenic therapy for cancer and other angiogenic diseases are considered.

Main Results:

  • Arsenic exhibits context-dependent effects on angiogenesis, acting as an inhibitor in some cancer treatments and a promoter in others.
  • Key molecular pathways modulated by arsenic include VEGF signaling, inflammatory responses, and cellular proliferation.
  • The pro-angiogenic effect of arsenic contributes to its carcinogenic potential.

Conclusions:

  • Arsenic possesses a complex, dual role in regulating angiogenesis, necessitating careful consideration for therapeutic use.
  • A comprehensive understanding of arsenic's mechanisms is essential for optimizing its application in oncology and other angiogenic diseases.
  • Further research is warranted to fully delineate the therapeutic window and potential risks associated with arsenic-based treatments.